Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 known ✓ | P04629 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 17/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.47 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15446074 | 0.96 | TRPV1 (0.76) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| SCHEMBL616146 | 0.96 | TRPV1 (0.76) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| Hydrochloric Acid SCHEMBL3765639 | 0.95 | TRPV1 (0.75) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| SCHEMBL620089 | 0.89 | TRPV1 (0.74) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| SCHEMBL620565 | 0.89 | TRPV1 (0.65) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| SCHEMBL618146 | 0.87 | TRPV1 (0.73) | TRPV1CYP3A4CYP2D6 | |
| SCHEMBL619844 | 0.87 | TRPV1 (0.64) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| SCHEMBL619727 | 0.87 | TRPV1 (0.64) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| SCHEMBL617464 | 0.87 | TRPV1 (0.63) | TRPV1CYP3A4CYP2D6CCNE1CDK2 | |
| Grc-6211 SCHEMBL23390581 | 0.86 | TRPV1 (0.79) | TRPV1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1931681-B1 | SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS | GLENMARK PHARMACEUTICALS SA (CH) | 2012-11-14 | — | — | EP | claimed |
| US-7842703-B2 | Substituted benzofused derivatives and their use as vanilloid receptor ligands | GLENMARK PHARMACEUTICALS S.A. (CH) | 2010-11-30 | — | — | US | claimed |